Holen Sie sich die Stockscreener-App
23.35
1.23%
-0.29
Handel nachbörslich:
23.35
Schlusskurs vom Vortag:
$23.64
Offen:
$23.57
24-Stunden-Volumen:
297.60K
Relative Volume:
0.37
Marktkapitalisierung:
$1.40B
Einnahmen:
$439.00K
Nettoeinkommen (Verlust:
$-105.64M
KGV:
-12.97
EPS:
-1.8
Netto-Cashflow:
$-60.70M
1W Leistung:
-6.11%
1M Leistung:
-10.05%
6M Leistung:
-27.05%
1J Leistung:
-48.31%
1-Tages-Spanne:
$23.23
$24.00
1-Wochen-Bereich:
$22.90
$25.22
52-Wochen-Spanne:
$21.97
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
Firmenname
Janux Therapeutics Inc
Sektor
Branche
Telefon
(858) 751-4493
Adresse
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Vergleichen Sie JANX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
23.35 | 1.42B | 439.00K | -105.64M | -60.70M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Eingeleitet | Raymond James | Outperform |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-12-03 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-09-06 | Eingeleitet | Stifel | Buy |
| 2024-05-30 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-03-21 | Eingeleitet | BTIG Research | Buy |
| 2024-03-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-06 | Eingeleitet | Wedbush | Outperform |
| 2022-11-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Janux Therapeutics Inc Aktie (JANX) Neueste Nachrichten
How to integrate Janux Therapeutics Inc. into portfolio analysis toolsTrade Ideas & Scalable Portfolio Growth Methods - Newser
Should you wait for a breakout in Janux Therapeutics Inc.2025 Volatility Report & Fast Entry High Yield Tips - Newser
What moving averages say about Janux Therapeutics Inc.July 2025 Closing Moves & Safe Entry Point Identification - Newser
Can momentum traders help lift Janux Therapeutics Inc.Market Sentiment Summary & Weekly Momentum Stock Picks - Newser
How to escape a deep drawdown in Janux Therapeutics Inc.Weekly Trade Recap & Verified Technical Trade Signals - Newser
Will Janux Therapeutics Inc. stock recover after recent dropQuarterly Profit Summary & Daily Market Momentum Tracking - Newser
Can swing trading help recover from Janux Therapeutics Inc. lossesShare Buyback & Free Daily Entry Point Trade Alerts - Newser
Tools to monitor Janux Therapeutics Inc. recovery probabilityTrade Volume Summary & Daily Chart Pattern Signals - Newser
Custom strategy builders for tracking Janux Therapeutics Inc.Trade Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Multi asset correlation models including Janux Therapeutics Inc.Weekly Investment Report & Entry Point Confirmation Signals - Newser
Technical signs of recovery in Janux Therapeutics Inc.Trade Ideas & Real-Time Chart Breakout Alerts - Newser
Applying Wyckoff theory to Janux Therapeutics Inc. stockQuarterly Earnings Report & Real-Time Volume Analysis - Newser
Will breakout in Janux Therapeutics Inc. lead to full recoveryWeekly Gains Report & Smart Swing Trading Techniques - Newser
Has Janux Therapeutics Inc. formed a bullish divergenceJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Published on: 2025-08-26 10:09:09 - Newser
Janux Therapeutics Inc. stock daily chart insightsMarket Volume Report & Expert Curated Trade Setup Alerts - Newser
Can a trend reversal in Janux Therapeutics Inc. lead to recoveryCEO Change & Accurate Intraday Trade Tips - Newser
AI Indicators Detect Buy Opportunity in Janux Therapeutics Inc.2025 Market Sentiment & Fast Moving Stock Watchlists - beatles.ru
Using data filters to optimize entry into Janux Therapeutics Inc.Portfolio Gains Report & Risk Controlled Stock Pick Alerts - Newser
Published on: 2025-08-27 13:37:05 - Newser
Janux Therapeutics Inc. Ranks High in Smart Money Tracker2025 Big Picture & Low Volatility Stock Recommendations - beatles.ru
Live market analysis of Janux Therapeutics Inc.Insider Buying & Breakout Confirmation Trade Signals - Newser
Tick level data insight on Janux Therapeutics Inc. volatility2025 Price Targets & Low Risk Entry Point Tips - Newser
Applying Elliott Wave Theory to Janux Therapeutics Inc.Earnings Beat & Safe Entry Zone Identification - Newser
AI Tools Suggest Janux Therapeutics Inc. May Outperform This Week2025 Trading Recap & Safe Capital Growth Plans - mustnews.co.kr
Guggenheim Initiates Coverage on Janux Therapeutics with Buy Rating and $42.00 Target - AInvest
Janux Therapeutics Inc. Shows Early Signs of Technical Strength2025 EndofYear Setup & Weekly Hot Stock Watchlists - 더경남뉴스
Summit stock gets Neutral view at Piper Sandler (SMMT:NASDAQ) - Seeking Alpha
Janux Therapeutics Receives $10M Milestone Payment from Merck for Advancing Cancer Therapy Collaboration - MSN
Piper Sandler initiates coverage of oncology companies (CGON:NASDAQ) - Seeking Alpha
Janux Therapeutics shares fall 2.08% intraday as Piper Sandler maintains its stance on the biopharma company. - AInvest
Combining price and volume data for Janux Therapeutics Inc.Earnings Growth Summary & Verified Stock Trade Ideas - Newser
Janux Therapeutics Inc. stock retracement – recovery analysisPortfolio Risk Report & AI Forecast Swing Trade Picks - Newser
9 Best Small Cap Stocks with Biggest Upside Potential - Insider Monkey
Is Janux Therapeutics Inc. a candidate for recovery play2025 Earnings Surprises & High Return Stock Watch Alerts - Newser
Chart based exit strategy for Janux Therapeutics Inc.Dividend Hike & AI Optimized Trading Strategy Guides - Newser
What MACD and RSI say about Janux Therapeutics Inc.Market Trend Summary & Consistent Profit Trade Alerts - Newser
Will Janux Therapeutics Inc. continue its uptrend2025 Macro Impact & AI Powered Market Trend Analysis - Newser
Finanzdaten der Janux Therapeutics Inc-Aktie (JANX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):